Teva Pharmaceutical Industries (NYSE:TEVA) recently received FDA acceptance of its supplemental Biologics License Application ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we ...

The healthcare sector is tearing in two amid the stock market’s tariff-induced turmoil. Investors looking for safety from ...

Bearish flow noted in Teva (TEVA) with 36,896 puts trading, or 26x expected. Most active are Apr-25 12.5 puts and May-25 16 calls, with total ...

Analysts at Zacks Research raised their FY2025 earnings per share estimates for shares of Teva Pharmaceutical Industries in a ...

EPYSQLI ® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, ...

Israel-based Teva Pharmaceuticals industries (NYSE: TEVA) today revealed two important updates reflecting its commitment to ...

EPYSQLI is designed to treat gMG in adults who are anti-acetylcholine receptor antibody positive.

Explore the impact of proposed Pharma tariffs on global markets as major stocks tumble. Click for my updated look at selected picks in the health industry.

Investing.com – Israel stocks were higher after the close on Monday, as gains in the Banking, Oil & Gas and Financials sectors led ...

If approved for an expanded pediatric indication, AJOVY would be the first calcitonin gene-related peptide (CGRP) antagonist for migraine prevention in adults and episodic migraine prevention in ...